A Feasibility Device Study to Prevent Female Urinary Stress Incontinence

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-04

Study Completion Date

2017-05-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will test the acute efficacy of an investigational device (Yoni.Fit) in a clinical trial of women with incontinence in a standardized set of challenges performed with and without the device in place.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Evaluating the Efficacy and Safety of Yoni.Fit in Women With Stress Urinary Incontinence

NCT03978741

Urinary Incontinence

COMPLETED NA

A Clinical Evaluation of the Tension-Free Vaginal Tape Obturator System For Treatment of Stress Urinary Incontinence (Urinary Leakage)

NCT00196521

Stress Urinary Incontinence

COMPLETED NA

Continence Pessary Versus Disposable Intravaginal Device Trial

NCT03174431

Female Stress Incontinence

COMPLETED NA

The AttenueX IntraVesical System for the Treatment of Female Stress Urinary Incontinence

NCT00492596

Urinary Incontinence, Stress

COMPLETED PHASE3

Cystic Fibrosis and Urinary Incontinence

NCT04922255

Urinary Incontinence Cystic Fibrosis

TERMINATED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Potential subjects will be pre-qualified by a 6-item questionnaire, the validated Questionnaire for Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score. For privacy reasons, these scores will not be retained. Subjects will then be given an appointment. Subjects will be instructed to wear comfortable athletic type wear and not to drink any fluid for two hours prior to their appointment.
2. When subjects appear for their appointment, subjects will be administered the informed consent by the Study Coordinator. All paperwork will be pre-numbered with a code that will link to the subject name. The key will be kept confidential by the Study Coordinator. They will be instructed to empty their bladders and will be given a liter of water or other drink and instructed to drink it over a 15-20 minute time period. An abbreviated patient history will be obtained for the purpose of establishing whether the subject meets the inclusion criteria and is not disqualified by meeting the exclusion criteria. The subject will again fill out the QUID questionnaire. The inclusion criteria are a SUI score of 5 or greater, predominately SUI (SUI score\>UUI score) and age between 25 and 65. Exclusion criteria are predominantly UUI, prolapse greater than mild, hysterectomy or other pelvic floor surgery other than a Caesarian section, diabetes, pregnant, BMI\>35 or unable to perform ten "jumping jack" exercises. Patients will be administered three additional questionnaires in order to compute a Severity Score. These questionnaires are the Urinary Distress Inventory (UDI), Urinary Impact Questionnaire (UIQ) and the Incontinence Severity Index (ISI). The scores will be multiplied together to provide the Severity Score.
3. Patients will be randomized to Group A or Group B to participate in an abbreviated Pad Test. Group A will perform the test with the Yoni.Fit device in place then repeat the test without the device. Group B will perform the test without the Yoni.Fit device in place then repeat the test with the device in place. This test has been validated (5). An hour after finishing the liter of liquid, the subject is given a tared incontinence pad, which is then put in place. She then engages in the following mild exercise challenges..

1. Stand from sitting 10 times.
2. Cough vigorously while standing.
3. Bend down to pick up small object.
4. Perform ten jumping jacks. The subject then will remove pad, place into bag and seal. The Experimenter will then weigh pad. The subjects will be randomized so that half will perform the Abbreviated Pad Test with the Yoni.Fit device in place followed by repeating without the device in place. The other half will perform the challenges in the reverse order.
4. The experimenter will calculate a change in score, which is the weight of the pad worn without the device in place minus the tare weight of the pad divided by the weight of the pad with the device in place minus the tare weight of the pad. In case no urine is released with the device in place, the Improvement Score will be defined as "1000". A Release Change will also be calculated as the net weight without the device in place minus the weight with the device in place divided by the net weight released without the device in place.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stress Incontinence, Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

With Yoni.Fit

Subjects will perform the Abbreviated Pad Test with the Yoni.Fit first, then without the Yoni.Fit.

Group Type EXPERIMENTAL

With Yoni.Fit

Intervention Type DEVICE

Abbreviated Pad Test with Yoni.Fit first, then without Yoni.Fit.

Without Yoni.Fit

Subjects will perform the Abbreviated Pad Test without the Yoni.Fit first, then with the Yoni.Fit.

Group Type EXPERIMENTAL

Without Yoni.Fit

Intervention Type DEVICE

Abbreviated Pad Test without Yoni.Fit, then with Yoni.Fit.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

With Yoni.Fit

Abbreviated Pad Test with Yoni.Fit first, then without Yoni.Fit.

Intervention Type DEVICE

Without Yoni.Fit

Abbreviated Pad Test without Yoni.Fit, then with Yoni.Fit.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Urinary Incontinence Diagnosis (QUID). This questionnaire has 3 questions each referring to the seriousness of Stress Urinary Incontinence (SUI) and of Urge Urinary Incontinence (UUI). Subjects will be accepted if their SUI score is 5 or greater and is greater than the UUI score.

Exclusion Criteria

* Refusal to sign the informed consent document
* SUI score is less than 5 or is less than the UUI score.
* Predominantly UUI
* Prolapse greater than mild
* Hysterectomy or other pelvic floor surgery other than a Caesarian section
* Diabetes,
* Pregnant,
* BMI\>35 or unable to perform ten "jumping jack" exercises.

Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No